# Cytek Biosciences, Inc. Common Stock (CTKB)

> Cytek Biosciences, Inc. Common Stock (CTKB) trades at $6.12 (-3.16%) as of 7:53:00 PM EST on Nov 20, 2026, +12.71% over the past month. Market cap is $826.55M, with 3.6 days to cover in short interest.

Canonical: https://massive.com/quote/ctkb
Data as of: 2026-11-21T00:53:00.025Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$6.12** -0.20 (-3.16%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$6.35** +0.23 (+3.76%)
As of 7:53:00 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Cytek Biosciences, Inc. Common Stock (CTKB) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -3.16% |
| 1W | +4.79% |
| 1M | +12.71% |
| YTD | +21.19% |
| 1Y | +4.08% |
| 52-wk range | $3.31 – $6.39 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for CTKB: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $5.99 – $6.39 |
| Open | $6.31 |
| Prev close | $6.32 |
| Volume | 1.77M |
| Market cap | $826.55M |
| Shares out | 130.78M |

## Valuation and profitability ratios

Valuation and profitability ratios for Cytek Biosciences, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 3.98 |
| P/B | 2.57 |
| P/FCF | — |
| ROE | -25.3% |
| ROA | -18.2% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 19, 2026

## Insider trading

[Cytek Biosciences, Inc. Common Stock (CTKB) insider trading](https://massive.com/quote/ctkb/insider-trading.md): open-market Form 4 buys and sells by Cytek Biosciences, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Cytek Biosciences, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 4, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 4, 2026, Cytek Biosciences, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026.”
- Sep 29, 2026 · Bylaw amendment
  “On September 23, 2026, the board of directors of Cytek Biosciences, Inc. unanimously adopted amended and restated bylaws of the Company (as amended and restated, the “A&R Bylaws”), effective as of such adoption date. The amendments included additional information and representations for stockholder proposals and director nominees, expanded the chairperson’s authority to disregard non-compliant nominations and proposals, incorporation of the universal proxy rules, and advance-notice and disqualification procedures for special-meeting nominations.”
- Aug 24, 2026 · Material litigation
  “On August 21, 2026, the Company announced that a jury in the United States District Court for the District of Delaware returned a verdict in the patent infringement action brought by Beckman Coulter, Inc. The jury found in the Company's favor on three of the four asserted patent claims, finding noninfringement and invalidity as to each of those three claims. With respect to one claim, the jury found no literal infringement but found infringement under the doctrine of equivalents. The jury awarded past damages consisting of $20 million in lost profits and $36.11 million in royalties.”
- Jul 15, 2026 · [Executive officer departure](https://massive.com/quote/sec-filings/8-k/executive-departures.md)
  “Valerie Barnett's position as Chief Legal Officer and Corporate Secretary of Cytek Biosciences, Inc. (the "Company") terminated on June 29, 2026.”
- Jun 25, 2026 · [Executive officer departure](https://massive.com/quote/sec-filings/8-k/executive-departures.md)
  “On June 18, 2026, Valerie Barnett and Cytek Biosciences, Inc. (the "Company") agreed that Ms. Barnett's position as Chief Legal Officer and Corporate Secretary of the Company would terminate effective as of June 29, 2026. Ms. Barnett's separation is not due to any disagreement with the Company's operations, policies or practices.”

## CTKB short interest

How heavily CTKB is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 3.6 |
| Short interest | 4.11M |
| Avg volume | 1.15M |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## CTKB news

The latest news and headlines about Cytek Biosciences, Inc. Common Stock (CTKB).

- [Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year](https://www.globenewswire.com/news-release/2026/11/05/3397196/0/en/cytek-aurora-evo-system-wins-biotech-breakthrough-award-for-drug-discovery-innovation-of-the-year.html) · GlobeNewswire Inc. · Nov 5, 2026 · positive sentiment
- [Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for](https://www.zacks.com/stock/news/3017154/analysts-estimate-cytek-biosciences-inc-ctkb-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-fundamental_analysis|yseop_template_9-3017154) · Zacks Investment Research · Oct 28, 2026 · negative sentiment
- [Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026](https://www.globenewswire.com/news-release/2026/06/02/3305669/0/en/Cytek-Biosciences-to-Unveil-Next-Generation-Spectral-Flow-Cytometry-Innovations-at-CYTO-2026.html) · GlobeNewswire Inc. · Jun 2, 2026 · positive sentiment
- [Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact](https://www.globenewswire.com/news-release/2026/03/09/3252344/0/en/Cytek-Biosciences-Celebrates-One-Year-of-Operations-at-Singapore-Facility-Accelerating-Growth-and-Regional-Impact.html) · GlobeNewswire Inc. · Mar 9, 2026 · positive sentiment
- [Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results](https://www.globenewswire.com/news-release/2026/01/12/3216614/0/en/Cytek-Biosciences-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2025-Revenue-Results.html) · GlobeNewswire Inc. · Jan 12, 2026 · positive sentiment

## About Cytek Biosciences, Inc. Common Stock

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 703 |
| Listed | Jul 23, 2021 |

[Company website](https://www.cytekbio.com)

## FAQ

### What is the Cytek Biosciences, Inc. Common Stock (CTKB) stock price today?

Cytek Biosciences, Inc. Common Stock (CTKB) is trading at $6.12 (-3.16% on the day) as of 7:53:00 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Cytek Biosciences, Inc. Common Stock?

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single…

### What is the short interest in CTKB?

As of Oct 30, 2026, CTKB has 4.11M shares short and 3.6 days to cover.

### What exchange is CTKB listed on?

Cytek Biosciences, Inc. Common Stock (CTKB) trades on Nasdaq in USD, in the LABORATORY ANALYTICAL INSTRUMENTS industry.

## Live data

Prices here are 15-minute delayed. For real-time CTKB quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=CTKB`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Cytek Biosciences, Inc. Common Stock (CTKB) insider trading](https://massive.com/quote/ctkb/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
